Landscapes / Companies
Enliven Therapeutics not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials
Trials
5 active
5 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 31 Dec 2028Phase 3 trial completes | |||
| Next date | 31 Dec 2028 · Phase 3 trial completes | ||||
| Also tested for | Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive and 6 more | ||||
| Open drug page | |||||
— |
Phase 1 | Jan 2027Phase 1 trial completes | |||
| Next date | Jan 2027 · Phase 1 trial completes | ||||
| Also tested for | HER2 Amplification, HER2 Mutant Non-small Cell Lung Cancer and 6 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021